What Can We Expect From Long-Acting Formulations for Schizophrenia?

Content Type Journal Article
Category CLINICAL TRIAL REPORT
Pages 243-244
DOI 10.1007/s11920-011-0206-2
Authors
- Steven J. Siegel, Division of Translational Neuroscience, Department of Psychiatry, University of Pennsylvania, Translational Research Laboratories, 125 South 31st Street, Philadelphia, PA 19104, USA